DHIL vs IDXX · P/E 9.8, rev $151.1M vs P/E 40, rev $2.36B
Diamond Hill Investment Group Inc (DHIL) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Diamond Hill Investment Group Inc (DHIL) is a asset management company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported DHIL revenue for 2024-12-31 was $151.1M. Net income was $43.2M. Revenue was up 10.5% from 2023-12-31 to 2024-12-31. DHIL currently screens at market cap $473.3M and trailing P/E 9.8.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
DHIL currently screens at market cap $473.3M and trailing P/E 9.8. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the DHIL and IDXX stock pages for the full models.
Not investment advice.